Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Translin-associated factor X-interacting protein 1 (TSNAXIP1) is a cytoplasmic adaptor/scaffold protein encoded on human chromosome 16q22.1 and is highly expressed in testicular tissue. Its main known biological roles are in spermatogenesis and cell differentiation, but its precise function in cellular signaling or biochemistry is not fully characterized. TSNAXIP1 is not recognized as a classic therapeutic target such as a receptor, enzyme, ion channel, or transporter, but genetic evidence links it to male fertility and possibly some cancer contexts. There is no evidence it is directly targeted by therapeutics or used as a diagnostic or prognostic biomarker[1][5][7][9][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Translin-associated factor X-interacting protein 1 (TSNAXIP1).